RetinalGenix Technologies (RTGN) Debt Ratio (2021 - 2026)
RetinalGenix Technologies (RTGN) posted Debt Ratio of 8.44 for Q1 2026, up 81.23% sequentially from 4.66 in Q4 2025, and up 105.53% YoY from 4.11 in Q1 2025.
RetinalGenix Technologies (RTGN) Debt Ratio (2021 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Debt Ratio for 6 years, with the latest figure at 8.44 in Q1 2026.
- Quarterly Debt Ratio rose 105.53% year-over-year to 8.44 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.44 (up 105.53% YoY) and the FY2025 annual result came in at 4.66, up 42.07% from the prior year.
- Debt Ratio advanced to 8.44 in Q1 2026 per RTGN's latest filing, from 4.66 in the prior quarter.
- Over five years, Debt Ratio peaked at 2703.7 in Q2 2022 and troughed at 0.55 in Q3 2024.
- A 5-year average of 216.16 and a median of 7.0 in 2025 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2022 and 2024: Debt Ratio jumped 2158.9% in 2022, then slumped 99.75% in 2024.
- Over 5 years, Debt Ratio stood at 333.33 in 2022, then fell by 5.77% to 314.1 in 2023, then tumbled by 98.96% to 3.28 in 2024, then surged by 42.07% to 4.66 in 2025, then jumped by 81.23% to 8.44 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 8.44, 4.66, and 7.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.18 |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 8.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.44 |
| Dec 31, 2025 | 4.66 |
| Sep 30, 2025 | 7.00 |
| Jun 30, 2025 | 5.84 |
| Mar 31, 2025 | 4.11 |
| Dec 31, 2024 | 3.28 |
| Sep 30, 2024 | 0.55 |
| Jun 30, 2024 | 0.56 |
| Mar 31, 2024 | 0.97 |
| Dec 31, 2023 | 314.10 |
| Sep 30, 2023 | 217.78 |
| Jun 30, 2023 | 23.12 |
| Mar 31, 2023 | 6.36 |
| Dec 31, 2022 | 333.33 |
| Sep 30, 2022 | 12.26 |
| Jun 30, 2022 | 2,703.70 |
| Mar 31, 2022 | 28.57 |
| Dec 31, 2021 | 14.76 |
| Sep 30, 2021 | 4.49 |